Last reviewed · How we verify
MAGNESIUM OXYBATE
At a glance
| Generic name | MAGNESIUM OXYBATE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 2020 |
Approved indications
Common side effects
Key clinical trials
- Low Sodium Oxybate in Patients With Idiopathic Hypersomnia (PHASE4)
- A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MAGNESIUM OXYBATE CI brief — competitive landscape report
- MAGNESIUM OXYBATE updates RSS · CI watch RSS